Not a chance this is retail investors selling. This is def shorting. You would have to be really dumb to sell at these levels or in situation where you couldn’t afford to keep your lights on or food on the table even than it’s not a wise idea. This whole 13-D things secondary objective could be to tank the price as low as they can and if they think the drug is amazing like they say buy up all the shares they can at these record lows, they also could wait to time major short covering prior to trial results or if board member ever got elected make it look like it was a positive thing for the company. To me it’s all a distraction I just sit back abs accumulate when I can. I think the drug will be much more valuable in the hands of a CEO that believes this is a triple digit company. These 13-D believe it’s a $1.25 cent company.